Correlation of somatostatin receptor PET/CT imaging features and immunohistochemistry in neuroendocrine tumors of the lung: a retrospective observational study.
Carcinoid Tumor
Fluorodeoxyglucose F18
Gallium Radioisotopes
Humans
Immunohistochemistry
Ki-67 Antigen
Lung
/ pathology
Lung Neoplasms
/ diagnostic imaging
Neuroendocrine Tumors
/ diagnostic imaging
Organometallic Compounds
Positron Emission Tomography Computed Tomography
Receptors, Somatostatin
/ analysis
Retrospective Studies
Somatostatin
Immunohistochemistry
Ki-67
Lung NET
PET/CT
Somatostatin receptor subtypes
[68Ga]-DOTA-somatostatin analogs
Journal
European journal of nuclear medicine and molecular imaging
ISSN: 1619-7089
Titre abrégé: Eur J Nucl Med Mol Imaging
Pays: Germany
ID NLM: 101140988
Informations de publication
Date de publication:
Oct 2022
Oct 2022
Historique:
received:
18
01
2022
accepted:
22
05
2022
pubmed:
9
6
2022
medline:
5
10
2022
entrez:
8
6
2022
Statut:
ppublish
Résumé
To correlate somatostatin receptor (SSTR) and proliferative activity profile (SSTR2, SSTR5, Ki-67) at immunohistochemistry (IHC) with SSTR-PET/CT imaging features in a retrospective series of lung neuroendocrine tumors (NET). Proliferative activity by Ki-67 and Among 551 patients who underwent SSTR-PET/CT with Definitive diagnosis consisted of 26 typical carcinoids-G1 and six atypical carcinoids-G2. Positive SSTR2-IHC was found in 62.5% of samples while SSTR5-IHC positivity was 19.4%. A correlation between SSTR2-IHC and SSTR-PET/CT was found in 24/32 cases (75.0%, p = 0.003): 20 were concordantly positive, 4 concordantly negative. For positive IHC, 100% concordance with SSTR-PET/CT (both positive) was observed, while for negative IHC concordance (both negative) was 33.3%. In 8 cases, IHC was negative while SSTR-PET/CT was positive, even though with low-grade uptake in all but one. A significant correlation between SUV This retrospective study showed an overall good agreement between SSTR2-IHC and tumor uptake at SSTR-PET/CT in lung NETs. SSTR-PET/CT SUV
Identifiants
pubmed: 35674739
doi: 10.1007/s00259-022-05848-z
pii: 10.1007/s00259-022-05848-z
pmc: PMC9525360
doi:
Substances chimiques
Gallium Radioisotopes
0
Ki-67 Antigen
0
Organometallic Compounds
0
Receptors, Somatostatin
0
Fluorodeoxyglucose F18
0Z5B2CJX4D
Somatostatin
51110-01-1
Types de publication
Journal Article
Observational Study
Langues
eng
Sous-ensembles de citation
IM
Pagination
4182-4193Commentaires et corrections
Type : ErratumIn
Informations de copyright
© 2022. The Author(s).
Références
Eur J Nucl Med Mol Imaging. 2015 Dec;42(13):2072-82
pubmed: 26219870
Front Endocrinol (Lausanne). 2021 Apr 27;12:669484
pubmed: 33986731
J Thorac Oncol. 2020 Oct;15(10):1577-1598
pubmed: 32663527
Chest. 2001 Jun;119(6):1647-51
pubmed: 11399686
J Nucl Med. 2021 Oct;62(10):1323-1329
pubmed: 34301785
Tumour Biol. 2014 Sep;35(9):8369-77
pubmed: 24850179
Endocr Pathol. 2004 Winter;15(4):275-91
pubmed: 15681851
Eur J Endocrinol. 2004 Apr;150(4):565-77
pubmed: 15080788
J Nucl Med. 2010 Mar;51(3):353-9
pubmed: 20150249
Eur J Cancer. 2021 Mar;146:56-73
pubmed: 33588146
Anticancer Res. 2013 Oct;33(10):4219-28
pubmed: 24122985
Ann Oncol. 2010 Mar;21(3):548-555
pubmed: 19759190
Clin Nucl Med. 2015 Mar;40(3):e183-9
pubmed: 25608152
Eur J Nucl Med Mol Imaging. 2009 Jan;36(1):48-52
pubmed: 18807033
Medicine (Baltimore). 2019 Mar;98(10):e14769
pubmed: 30855482
Virchows Arch. 2001 Dec;439(6):787-97
pubmed: 11787852
Eur J Nucl Med. 2000 Mar;27(3):273-82
pubmed: 10774879
Mod Pathol. 2018 Dec;31(12):1770-1786
pubmed: 30140036
Mod Pathol. 2007 Nov;20(11):1172-82
pubmed: 17873898
J Nucl Med. 2017 Sep;58(Suppl 2):54S-60S
pubmed: 28864613
Eur J Nucl Med Mol Imaging. 2011 Sep;38(9):1659-68
pubmed: 21626438
Gastroenterology. 1994 Apr;106(4):951-9
pubmed: 8144000
Front Med (Lausanne). 2020 Jan 29;6:336
pubmed: 32118000
Lung Cancer. 2020 Dec;150:70-75
pubmed: 33075738
Eur J Nucl Med Mol Imaging. 2012 Apr;39(4):569-80
pubmed: 22223169
J Clin Endocrinol Metab. 2019 Jun 1;104(6):2083-2093
pubmed: 30657933
Radiographics. 2015 Mar-Apr;35(2):500-16
pubmed: 25763733
Neuroendocrinology. 2017 Mar 30;105(3):212-244
pubmed: 28355596
Biometrics. 1977 Mar;33(1):159-74
pubmed: 843571